Synopsys Leverages AI to Accelerate Chip Design and Drive Growth

Arm Holdings and Qualcomm have entered a high-stakes federal trial over alleged breaches of their chip licensing agreements, centering on billions of dollars in potential royalty payments tied to Qualcomm designs that incorporate Arm architecture. Legal arguments focus on whether Qualcomm's use of Arm technology through certain partners falls within existing contract terms or requires fresh licenses, and Qualcomm is seeking to stop paying some royalties for up to five years. Arm Holdings licenses CPU, graphics and systems IP that underpins many smartphone and data-center chips, so the case puts the focus on how this US$323.2 billion semiconductor business enforces and monetises its core designs when large customers route production through complex partner structures. A ruling that weakens Arm's ability to enforce contracts with a large customer could challenge the thesis that rising royalty rates and AI-focused data center royalties support higher earnings. Investors can track the trial timetable through 2026, watch for interim rulings on contract interpretation, and scan Arm's future filings for quantified commentary on Qualcomm-related royalty exposure or any changes to licensing terms with big chip customers.

Synopsys has entered into a $1 billion accelerated share repurchase agreement with JPMorgan Chase Bank, National Association. Under the terms of the ASR, the Sunnyvale, California-based chip design software company will receive an initial delivery of approximately 1,735,000 shares, with any remainder to be settled on or before January 5, 2027. The final number of shares Synopsys repurchases will be based on the average of its daily volume-weighted average share prices during the repurchase period, less a discount. Synopsys trades on Nasdaq under the ticker SNPS.